GE's imaging marker spots Alzheimer's patients – study
This article was originally published in Clinica
Executive Summary
A positron emission tomography (PET) imaging agent developed by GE Healthcare, 18F flutemetamol, could help differentiate between Alzheimer's disease patients and healthy individuals.